New award for hydralazine HCL tablets with radha pharmaceuticals with four one-year options
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0013
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Hydralazine RFP Pre-Solicitation · 36E79725R0060 · Posted Oct 21, 2025
- Last date to order 35% complete
- IDV ceiling
- $7,450,452.50
- Award type
- Single award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The VA National Acquisition Center awarded a single-award indefinite-delivery contract to Radha Pharmaceuticals Inc. for the supply of Hydralazine HCl tablets on April 8, 2026, with a ceiling value of $7,450,452.50. The contract carries a base period through October 2, 2027, with four one-year option periods. This is an unrestricted competitive procurement with no set-aside applied. Radha Pharmaceuticals is a minority-owned manufacturer and distributor of generic pharmaceuticals.
The IDIQ supplies Hydralazine HCl tablets in multiple dosage strengths—100mg, 50mg, 25mg, and 10mg—in various bottle configurations to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Estimated annual requirements include 103,773 bottles of 100mg tablets, 5,481 bottles of 50mg tablets, 6,188 bottles of 25mg 100-count tablets, 29,343 bottles of 25mg 1000-count tablets, 6,279 bottles of 10mg 100-count tablets, and 12,283 bottles of 10mg 1000-count tablets. Products are distributed through the VA and DoD Pharmaceutical Prime Vendor Programs using firm-fixed pricing. The solicitation required products packaged in non-glass bottles with exact NDC numbers matching the label specification. FAR Part 12 commercial item procedures applied, with the pre-solicitation posted October 21, 2025, and proposal due date of November 12, 2025. The contract incorporates DEI clause 52.222-90.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0013?
36E79726D0013 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on April 8, 2026.
How much is contract 36E79726D0013 worth?
36E79726D0013's own ceiling is $7,450,453.
Who can order from contract 36E79726D0013?
36E79726D0013 is a single award indefinite delivery contract.
Was contract 36E79726D0013 competed?
The extent of competition for 36E79726D0013 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV